# Robert J. Mayer

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robert-j-mayer/

## Facts

| Field | Value |
| --- | --- |
| Citations | 51,235 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 110 |
| i10-index | 316 |
| Last Known Institution | Applied Natural Sciences |
| OpenAlex ID | https://openalex.org/A5055389521 |
| ORCID iD | https://orcid.org/0000-0002-9864-7042 |
| Works | 626 |

## Researcher papers

- [Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia](https://scholariq.org/papers/intensive-postremission-chemotherapy-in-adults-with-acute-myeloid-leukemia/)
- [Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781](https://scholariq.org/papers/phase-iii-trial-of-trimodality-therapy-with-cisplatin-fluorouracil-radiotherapy/)
- [Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer](https://scholariq.org/papers/effect-of-first-line-chemotherapy-combined-with-cetuximab-or-bevacizumab-on/)
- [Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)](https://scholariq.org/papers/gemcitabine-plus-bevacizumab-compared-with-gemcitabine-plus-placebo-in-patients/)
- [Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803](https://scholariq.org/papers/impact-of-physical-activity-on-cancer-recurrence-and-survival-in-patients-with/)
- [Impact of Number of Nodes Retrieved on Outcome in Patients With Rectal Cancer](https://scholariq.org/papers/impact-of-number-of-nodes-retrieved-on-outcome-in-patients-with-rectal-cancer/)
- [NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019](https://scholariq.org/papers/nccn-guidelines-insights-genetic-familial-high-risk-assessment-colorectal-2/)
- [Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered](https://scholariq.org/papers/patients-with-t-8-21-q22-q22-and-acute-myeloid-leukemia-have-superior-failure/)
- [Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/genetic-familial-high-risk-assessment-colorectal-version-1-2016-nccn-clinical/)
- [NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017](https://scholariq.org/papers/nccn-guidelines-insights-genetic-familial-high-risk-assessment-colorectal/)
- [NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020](https://scholariq.org/papers/nccn-guidelines-insights-colorectal-cancer-screening-version-2-2020/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Colorectal Cancer Surgical Treatments](https://scholariq.org/topics/colorectal-cancer-surgical-treatments/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)

## Researcher university

- [Applied Natural Sciences](https://scholariq.org/institutions/applied-natural-sciences/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.